Applied Therapeutics, Inc. (APLT)

Regulus Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	50.76	79.4	49.9	16.66	53.89	57.47
Short-Term Investments	-	-	-	13.92	26.94	39.36
Cash & Short-Term Investments	50.76	79.4	49.9	30.58	80.82	96.83
Cash Growth	-65.35%	59.12%	63.17%	-62.16%	-16.53%	149.21%
Other Receivables	-	-	-	0.28	0.53	0.51
Receivables	-	-	-	0.28	0.53	0.51
Prepaid Expenses	1.26	1.74	1.35	2.12	2.56	2.91
Other Current Assets	1.95	2.51	3.13	4.33	4.48	2.35
Total Current Assets	53.97	83.65	54.39	37.31	88.39	102.59
Property, Plant & Equipment	2.69	2.79	0.45	0.86	1.3	1.71
Other Long-Term Assets	0.25	0.25	-	0.2	0.2	0.2
Total Assets	56.91	86.69	54.83	38.36	89.89	104.51
Accounts Payable	4.87	4.43	1.74	4.53	9.46	0.64
Accrued Expenses	8.81	15.33	13.93	13.65	14.78	18.56
Short-Term Debt	-	-	0.31	0.62	0.79	1.07
Current Portion of Leases	0.43	0.41	0.43	0.48	0.44	0.41
Current Unearned Revenue	0.21	0.21	0.67	-	-	-
Other Current Liabilities	3.65	6.92	54.1	14.14	0.99	0.55
Total Current Liabilities	17.97	27.3	71.18	33.42	26.46	21.24
Long-Term Leases	2.27	2.39	0.04	0.41	0.89	1.33
Other Long-Term Liabilities	-	-	0.76	0.46	-	-
Total Liabilities	20.24	29.69	71.98	34.3	27.35	22.57
Common Stock	0.04	0.04	0.01	0.01	0	0
Additional Paid-In Capital	632.67	631.18	451.43	352.83	328.96	242.78
Retained Earnings	-596.04	-574.21	-468.59	-348.82	-266.32	-160.73
Comprehensive Income & Other	-	-	-	0.05	-0.11	-0.11
Total Common Equity	36.67	57.01	-17.15	4.06	62.54	81.94
Shareholders' Equity	36.67	57.01	-17.15	4.06	62.54	81.94
Total Liabilities & Equity	56.91	86.69	54.83	38.36	89.89	104.51
Total Debt	2.7	2.8	0.78	1.51	2.12	2.81
Net Cash (Debt)	48.06	76.6	49.12	29.07	78.7	94.02
Net Cash Growth	-67.11%	55.95%	68.99%	-63.07%	-16.29%	155.38%
Net Cash Per Share	0.33	0.55	0.58	0.77	3.07	4.28
Filing Date Shares Outstanding	141.58	141.58	105.89	48.11	26.22	26.01
Total Common Shares Outstanding	141.58	137.23	84.87	48.06	26.22	22.49
Working Capital	36	56.35	-16.8	3.88	61.93	81.36
Book Value Per Share	0.26	0.42	-0.20	0.08	2.39	3.64
Tangible Book Value	36.67	57.01	-17.15	4.06	62.54	81.94
Tangible Book Value Per Share	0.26	0.42	-0.20	0.08	2.39	3.64

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q